News
06-24-2011, 10:10 AM
Cancer Research UK scientists have discovered why a sub group of oestrogen-receptor-negative breast cancer patients could benefit from prostate cancer treatments which target the cell's androgen receptor - a key driver of prostate cancer, according to research published in The EMBO Journal today...
More... (http://www.medicalnewstoday.com/releases/229609.php)
More... (http://www.medicalnewstoday.com/releases/229609.php)